-
公开(公告)号:CZ161697A3
公开(公告)日:1998-06-17
申请号:CZ161697
申请日:1997-05-26
Applicant: HOECHST AG
Inventor: ALBUS UDO DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS JOCHEN DR , SCHOLZ WOLFGANG DR , SCHWARK JAN ROBERT DR , WEICHERT ANDREAS DR
IPC: A61K31/165 , A61K31/155 , A61P3/06 , A61P9/00 , A61P9/10 , C07C277/06 , C07C279/22 , C07C311/15 , C07C317/44 , C07C323/62
-
公开(公告)号:AT165351T
公开(公告)日:1998-05-15
申请号:AT91122406
申请日:1992-01-01
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , ENGLERT HEINRICH DR , KLEEMANN HEINZ-WERNER DR , GERHARDS HERMANN DR , SCHOELKENS BERNWARD PROF DR , BECKER REINHARD DR , LINZ WOLFGANG DR , CAILLE JEAN-CLAUDE , VEVERT JEAN-PAUL
IPC: A61K31/40 , A61K31/415 , A61K31/425 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/505 , A61K31/535 , A61K31/54 , A61K31/64 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D207/34 , C07D207/36 , C07D233/54 , C07D233/66 , C07D233/68 , C07D233/70 , C07D233/84 , C07D233/90 , C07D249/02 , C07D255/02 , C07D257/02 , C07D257/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D453/02 , C07D521/00
Abstract: Azole derivative of the general formula (I) in which A, L, O, R , X, Y, Z and q have the meanings given, a process for their preparation, pharmaceutical preparations and the use of the compounds are described. Azole derivatives of the formula I where the symbols have, for example, the following meanings: R = (C2-C10)-alkyl Z = nitrogen X and Y = independently of one another CR L = -CH2- q = zero or 1 A = biphenyl radical which is substituted, for example, by R R = halogen or hydrogen R = SO2-NH-CO-OR and R = phenyl, are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:CZ9701887A3
公开(公告)日:1998-05-13
申请号:CZ188797
申请日:1997-06-17
Applicant: HOECHST AG
Inventor: WEICHERT ANDREAS DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS JOCHEN DR , SCHWARK JAN-ROBERT DR , ALBUS UDO DR , SCHOLZ WOLFGANG DR
IPC: A61K31/165 , A01N1/02 , A01N47/44 , A61K31/10 , A61K31/155 , A61K31/18 , A61P3/06 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P35/00 , A61P43/00 , C07C279/10 , C07C279/20 , C07C279/22 , C07C303/40 , C07C311/19 , C07C311/47 , C07C317/42 , C07C317/50
CPC classification number: A61K31/155 , Y10S514/821 , Y10S514/825
-
公开(公告)号:CZ9700653A3
公开(公告)日:1998-05-13
申请号:CZ65397
申请日:1997-03-03
Applicant: HOECHST AG
Inventor: ALBUS UDO DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS JOCHEN DR , SCHOLZ WOLFGANG DR , SCHWAFK JAN ROBERT DR , WEICHERT ANDREAS DR
IPC: A61K31/165 , A01N1/02 , A61K31/155 , A61P9/00 , A61P9/08 , A61P9/10 , A61P35/00 , A61P43/00 , C07C279/22
CPC classification number: C07C279/22
-
公开(公告)号:CZ9603382A3
公开(公告)日:1998-05-13
申请号:CZ338296
申请日:1996-11-18
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , BRENDEL JOACHIM DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR , LANG HANS JOCHEN DR , ALBUS UDO DR , SCHOLZ WOLFGANG DR
IPC: A61K31/165 , A61P1/16 , A61P3/08 , A61P9/08 , A61P9/10 , A61P11/00 , A61P13/02 , A61P15/00 , A61P35/00 , A61P43/00 , C07C279/20 , C07C279/22
CPC classification number: C07C279/22
-
公开(公告)号:GR3024927T3
公开(公告)日:1998-01-30
申请号:GR970402568
申请日:1997-10-03
Applicant: HOECHST AG
Inventor: LANG HANS-JOCHEN DR , KLEEMANN HEINZ-WERNER DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: A61K31/165 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , C07C277/08 , C07C279/22 , C07C311/15 , C07C317/44 , C07C317/46 , C07C323/62 , C07D241/28
Abstract: There are described benzoylguanidines of the formula I where R(1) is H, Hal, -NO2, -C IDENTICAL N, Xo-(CH2)p-(CF2)q-CF3, R(5)- SOm, R(6)-CO- or R(6)R(7)NO-SO2-, where X is O, S, NR(14), m is 0-2, o is 0, 1, p is 0-2, q is 0-6, R(5) and R(6) are alk(en)yl, -CnH2n-R(8), CF3, n is 0-4, R(8) is cycloalkyl, phenyl, R(6) also being H, R(2) is where Y is O, -S- or -NR(12)-; R(11), R(12) = H, alkyl, and h is zero or 1, and i, j and k are 0-4, but where h, i and k are not simultaneously zero, R(3) is defined as R(1), or is alkyl, -X-R(13) where X is O, S, NR(14), R(14) is H, alkyl, R(13) is H, (cyclo)alkyl, -CbH2b-R(15) where b is 0-4, R(15) is phenyl, R(4) is H, -OR(16) or -NR(16)R(17) where R(16), R(17) are H, alkyl and their pharmaceutically tolerable salts. They are obtained from a compound II by reaction with guanidine, in which R(1) to R(4) have the meaning indicated and L is a leaving group which can be easily nucleophilically substituted. The compounds are outstandingly suitable as antiarrhythmic medicaments having a cardioprotective component for infarct prophylaxis and infarct treatment and also for the treatment of angina pectoris, where they also preventively inhibit or severely decrease the pathophysiological processes in the formation of ischaemically induced damage, in particular in the elicitation of ischaemically induced cardiac arrhythmias.
-
公开(公告)号:AT161532T
公开(公告)日:1998-01-15
申请号:AT94111575
申请日:1994-07-25
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR , SCHOLZ WOLFGANG DR , ALBUS UDO DR
IPC: C07D233/64 , A01N1/02 , A61K31/40 , A61K31/41 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61P1/16 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P11/00 , A61P13/02 , A61P13/08 , A61P13/12 , A61P15/00 , A61P25/28 , A61P35/00 , A61P43/00 , C07C279/22 , C07D207/333 , C07D207/337 , C07D213/30 , C07D231/12 , C07D233/54 , C07D233/58 , C07D521/00
Abstract: The invention relates to benzoylguanidines of the formula I where R(1) is H, Hal, -NO2, -C IDENTICAL N, Xo-(CH2)p-(CF2)q-CF3, R(5)SOm, R(6)-CO-, R(6)R(7)N-CO- or R(6)R(7)N-SO2-, where X is oxygen, S, NR(14), m is zero, 1 or 2, o is zero, 1, p is zero, 1, 2, q is zero, 1, 2, 3, 4, 5, 6, R(5) and R(6) are alk(en)yl, -CnH2n-R(8), CF3, n is zero, 1, 2, 3 or 4, R(8) is cycloalkyl, phenyl, where R(6) also has the meaning of H, R(7) is H or alkyl; R(2) is R(11) is (C1-C9)-heteroaryl, Y is oxygen, -S- or NR(12)-, R(12) is H, (C1-C4)-alkyl; R(3) is defined as R(1), or is alkyl, -X-R(13) where X is oxygen, S, NR(14), R(14) is H, (C1-C3)-alkyl, R(13) is H, (cyclo)alkyl, -CbH2b-R(15) where b is zero to 4 and R(15) is phenyl; R(4) is hydrogen, -OR(16), -NR(16)R(17) or CrF2r+1 where R(16), R(17) independently are hydrogen, (C1-C3)-alkyl, r is 1-4 and their pharmaceutically tolerable salts. The compounds I are outstandingly suitable as antiarrhythmic medicaments having a cardioprotective component for infarct prophylaxis and for infarct treatment and for the treatment of angina pectoris.
-
公开(公告)号:ID17038A
公开(公告)日:1997-12-04
申请号:ID971869
申请日:1997-06-02
Applicant: HOECHST AG
Inventor: WEICHERT ANDREAS DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS JOCHEN DR , SCHWARK JAN-ROBERT DR , ALBUS UDO DR , SCHOLZ WOLFGANG DR
IPC: A61K31/165 , A01N1/02 , A01N47/44 , A61K31/155 , A61P3/00 , A61P3/06 , A61P7/04 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P35/00 , C07C279/22 , C07C319/20 , C07C323/62
Abstract: Ortho-substituted benzoyl-guanidines of formula (I) and their salts are new: R = H; F; Cl; Br; I; CN; NO2; 1-8 C alkyl; 1-8 C alkoxy; 3-8 C cycloalkyl; 3-8 C cycloalkoxy; Xa-(CH2)b-(CF2)c-CF3; SR ; OR ; CR R R ; Ph, etc.;R or R = OCOR and the other = R ;R , R = H; 1-4C alkyl; 1-4C alkoxy; etc.;X = e.g. O; a = 0 or 1;b = 0-2;c = 0-3;R = -CfH2f-Q;Q = e.g. 3-8 C cycloalkyl;f = 0-2; R , R = H; 1-4 C alkyl; or R ; R = e.g. 1-8C alkyl.
-
公开(公告)号:DE19621483A1
公开(公告)日:1997-12-04
申请号:DE19621483
申请日:1996-05-29
Applicant: HOECHST AG
Inventor: BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , ENGLERT HEINRICH CHRISTIAN DR , LANG HANS JOCHEN DR , SCHWARK JAN-ROBERT DR , WEICHERT ANDREAS DR , LAL BANSI
IPC: C07D295/14 , A01N1/02 , A01N47/44 , A61K31/155 , A61K31/165 , A61K31/27 , A61K31/44 , A61K31/495 , A61K31/535 , A61K31/5375 , A61P3/06 , A61P9/00 , A61P9/06 , A61P9/10 , A61P35/00 , A61P43/00 , C07C271/22 , C07C277/08 , C07C279/20 , C07C279/22 , C07C311/19 , C07C317/50 , C07C323/62 , C07D213/40 , C07D213/75 , C07D295/08 , C07D295/088
Abstract: 2-Naphthoyl-guanidines (I) and their salts are new: R1 and R3-R8 = H; F; Cl; Br; I; CN; NO2; CF3; C2F5; VpQqU; XYaWZ; or X'YaWZ' (at least 1 is XYaWZ or X'YaWZ'); V = O; S; SO; SO2; NR60; OCO; CO; CONR60; COO; or CR66R67; Q = 1-8C alkylene with 1 CH2 optionally replaced by O, S, NR13 or o-, m- or p-phenylene; U = H; 1-7C alkyl; 3-7C cycloalkyl; COR65; SO2R65; NR61R62; or Ph or a N- or C-linked N-containing 1-9C heterocycle optionally mono-, di- or trisubstituted by F, Cl, Br, CF3, Me, OMe or NR63R64; p, q = 0 or 1; X = O; S; NR10; or CR11R12; Y = 1-8C alkylene with 1 CH2 optionally replaced by O, S, NR13 or o-, m- or p-phenylene; W = CH2; SO2; S(O)(NH); or (when W is not attached directly to a hetero atom of XYa) O or NR14; Z = COR15; SO2R15; or (when W is not O or NR14) NR16R17; a = 0 or 1; X' = CO, CONR30, COO, SO, SO2, SO2NR30, OCO, NR30CO or NR30SO2 linked with the ring via the left hand atom; Z' = COR15; SO2R15; a N- or C-linked N-containing 1-9C heterocycle optionally mono-, di- or trisubstituted by F, Cl, Br, CF3, Me, OMe or NR21R22; or (when W is not O or NR14) Z' is NR16R17; R10-R12 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; R13, R14, R68 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-6C cycloalkyl; R15 = N=C(NH2)2; NR18R19; N(CH2)bNR18R19; or OR20; b = 2 or 3; R16 - R19 = H; 1-8C alkyl; or 1-4C perfluoroalkyl; or R16+R17 or R18+R19 = tetra- or pentamethylene with 1 CH2 optionally replaced by O, S or NA; A = H; Me; benzyl; or p-Cl-Ph; R20, R30; R60; R66; R67 = H; 1-6C alkyl; 1-4C perfluoroalkyl; or 3-7C cycloalkyl; R21, R22; R63, R64 = H; 1-4C alkyl; or 1-4C perfluoroalkyl; R65 = N=C(NH2)2; NR61R62; or OR60; R61, R62 = H; 1-8C alkyl; or 1-4C perfluoroalkyl; or R61+R62 = tetra- or pentamethylene with 1 CH2 optionally replaced by O, S or NA; provided that at least one of R5-R8 is not H.
-
公开(公告)号:DE19608161A1
公开(公告)日:1997-09-11
申请号:DE19608161
申请日:1996-03-04
Applicant: HOECHST AG
Inventor: WEICHERT ANDREAS DR , ALBUS UDO DR , BRENDEL JOACHIM DR , KLEEMANN HEINZ-WERNER DR , LANG HANS-JOCHEN DR , SCHOLZ WOLFGANG DR , SCHWARK JAN-ROBERT DR
IPC: A61K31/165 , A01N1/02 , A61K31/155 , A61P3/10 , A61P9/00 , A61P9/06 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/08 , A61P25/00 , A61P35/00 , A61P43/00 , C07C279/10 , C07C279/20 , C07C279/22 , C07C277/08 , C07D215/02 , C07D217/02 , C07D213/04
Abstract: Ortho-substituted benzoyl-guanidines of formula (I) and their salts are new: where R1 = H, F, Cl, Br, I, CN, NO2, 1-8C alkyl, 1-8C alkoxy, 3-8C cycloalkyl, 3-8C cycloalkoxy, Xa-(CH2)b-(CF2)c-CF3, SR10, OR10, CR10R11R12; or phenyl, naphthyl, biphenylyl, or 1-9C (sic) heteroaryl bonded via C or N and all optionally mono- to tri-substituted with F, Cl, CF3, CH3, methoxy, OH, NH2, NHCH3, NH(CH3)2; or SR13, OR13, NHR13, NR13R14, CHR13R15, CR15R16-OH, C IDENTICAL CR18, CR19=CHR18, ÄCR20R21Ük-CO, ÄCR22R23Ül-R24; one of R2, R3 = hydroxy the other as R1; R4 = 1-4C alkyl, 1-4C alkoxy, F, Cl, Br, I or (CH2)n-(CF2)o-CF3; X = O, S, NR5; a = 0-1; b = 0-2; c = 0-3; R5 = H, 1-4C alkyl, CdH2d-R6; d = 0-4; R6 = 3-8C cycloalkyl; or phenyl, biphenylyl or naphthyl (each optionally mono- to tri-substituted with F, Cl, CF3, methyl, methoxy, or NR7R8); R7, R8 = H or 1-4C alkyl; R10 = CfH2f-3-8C cycloalkyl; or phenyl optionally mono- to tri-substituted with F, Cl, CF3, CH3, methoxy, OH, NH2, NHCH3, NH(CH3)2; f = 0-2; R11, R12 = as R10, H or 1-4C alkyl; k = 0-4; l = 0-4; R13, R14 = (CH2)g-(CHOH)h-(CH2)i-(CHOH)j-R17, or (CH2)g-O-(CH2CH2O)h-R24; R17 = H, CH3; g, h, i = 0-4; j = 1-4; R15, R16 = H or 1-6C alkyl; or CR15R16 = 3-8C cycloalkyl; R18 = phenyl optionally mono- to tri-substituted with F, Cl, CF3, CH3, OCH3 or NR25R26; or 3-8C cycloalkyl; or 1-9C (sic) heteroaryl optionally substituted as for phenyl; or 1-6C alkyl optionally substituted by 1-3 OH; R25, R26 = H or 1-4C alkyl; R19-R23 = H or CH3; R24 = H, 1-6C alkyl, 3-8C cycloalkyl, CmH2m-R18; m = 1-4; n = 0-1; and o = 0-1.
-
-
-
-
-
-
-
-
-